Pages that link to "Q54360494"
Jump to navigation
Jump to search
The following pages link to Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4. (Q54360494):
Displaying 11 items.
- Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4 (Q28078574) (← links)
- Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4. (Q35745161) (← links)
- Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation (Q35745164) (← links)
- Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy (Q36398777) (← links)
- IRAK4 deficiency promotes cardiac remodeling induced by pressure overload (Q36492742) (← links)
- Inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4): a patent review (2012-2015). (Q38866932) (← links)
- Discovery and Structure Enabled Synthesis of 2,6-Diaminopyrimidin-4-one IRAK4 Inhibitors (Q42544740) (← links)
- TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis (Q48641496) (← links)
- Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia (Q50196157) (← links)
- Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy (Q57116991) (← links)
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects (Q91729155) (← links)